Appropriate Dosing to Optimise Personalised Cancer Treatments

Clinical trial NCT04154163 · COMPLETED

Trial details

NCT number: NCT04154163
Sponsor: University of Dundee
Status: COMPLETED
Study type: OBSERVATIONAL

Melanoma Stage III Melanoma Stage IV Ovarian Cancer Renal Cancer Stage III Renal Cancer Stage IV Lung Cancer, Non-small Cell

Start date: 2020-01-10
Primary completion: 2021-03-05
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.